Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 8/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.37 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL599704 | 0.87 | PARP10 (0.49) | PARP10KMT2AELANENR1H4MLYCD | |
| SCHEMBL12532571 | 0.87 | KMT2A (0.63) | PARP10KMT2AELANENR1H4MEN1 | |
| SCHEMBL22548942 | 0.82 | KMT2A (0.58) | PARP10KMT2ANR1H4LMNAPOLB | |
| SCHEMBL22548977 | 0.82 | KMT2A (0.58) | PARP10KMT2AELANENR1H4LMNA | |
| SCHEMBL27056408 | 0.81 | ALOX15 (0.56) | KMT2AMEN1LMNAPOLBMAPT | |
| SCHEMBL10591230 | 0.80 | ELANE (0.57) | PARP10KMT2AELANEMEN1CA1 | |
| SCHEMBL79929 | 0.79 | KMT2A (0.74) | PARP10KMT2ACA1CA2PKM | |
| SCHEMBL10867743 | 0.79 | KMT2A (0.74) | PARP10KMT2ACA1CA2PKM | |
| SCHEMBL8506170 | 0.79 | MAPT (0.59) | PARP10KMT2ALMNAPOLBMAPT | |
| SCHEMBL24813408 | 0.78 | HPGD (0.58) | PARP10KMT2AELANEMEN1PARP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3770181-A1 | METHOD FOR PREPARING HYALURONIC ACID HYDROGEL MIROPARTICLES AND USE THEREOF IN REPAIRING ARTICULAR CARTILAGE DEFECTS | Kaohsiung Medical University (TW) | 2021-01-27 | — | — | EP | claimed |
| US-20210015967-A1 | METHOD FOR PREPARING HYALURONIC ACID HYDROGEL MICROPARTICLES AND USE THEREOF IN REPAIRING ARTICULAR CARTILAGE DEFECTS | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2021-01-21 | — | — | US | claimed |
| WO-2019178825-A1 | METHOD FOR PREPARING HYALURONIC ACID HYDROGEL MIROPARTICLES AND USE THEREOF IN REPAIRING ARTICULAR CARTILAGE DEFECTS | 高雄医学大学 | 2019-09-26 | — | — | WO | claimed |
| US-20110301525-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-12-08 | — | — | US | claimed |
| US-20110189253-A1 | BIOMATERIAL COMPOSITION AND METHOD | WARSAW ORTHOPEDIC, INC. (US) | 2011-08-04 | — | — | US | claimed |
| US-20110182957-A1 | CELLULOSICS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-07-28 | — | — | US | claimed |
| US-12341195-B2 | Conducting polymer network-protected phosphorus anode active material for lithium-ion or sodium-ion batteries | HONEYCOMB BATTERY COMPANY (US) | 2025-06-24 | — | — | US | disclosed |
| US-12230790-B2 | Method of producing conducting polymer network-enabled particulates of anode active material particles for lithium-ion batteries | HONEYCOMB BATTERY COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| US-20240363867-A1 | CONDUCTING POLYMER NETWORK-PROTECTED CATHODE ACTIVE MATERIALS FOR LITHIUM SECONDARY BATTERIES | HONEYCOMB BATTERY COMPANY (US) | 2024-10-31 | — | — | US | disclosed |
| US-12009505-B2 | Conducting polymer network/graphene-protected negative electrode for a lithium-ion battery | HONEYCOMB BATTERY COMPANY (US) | 2024-06-11 | — | — | US | disclosed |
| US-20240097115-A1 | METHOD OF PRODUCING CONDUCTING POLYMER NETWORK-ENABLED PARTICULATES OF ANODE ACTIVE MATERIAL PARTICLES FOR LITHIUM-ION BATTERIES | HONEYCOMB BATTERY COMPANY (US) | 2024-03-21 | — | — | US | disclosed |
| US-11916223-B2 | Alkali metal-sulfur secondary battery containing conducting polymer network-protected cathode material particulates | GLOBAL GRAPHENE GROUP, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11881564-B2 | Method of improving the cycle stability of lithium metal secondary batteries | GLOBAL GRAPHENE GROUP, INC. (US) | 2024-01-23 | — | — | US | disclosed |
| US-20110182957-A1 | CELLULOSICS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-07-28 | — | — | US | disclosed |
| US-20110008277-A1 | POLYOL-BASED POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-01-13 | — | — | US | disclosed |
| EP-1773896-B1 | METHOD OF TREATING POLYMERS | CIBA SPEC CHEM WATER TREAT LTD (GB) | 2010-01-06 | — | — | EP | disclosed |
| WO-2009155583-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-12-23 | — | — | WO | disclosed |
| WO-2008144514-A2 | POLYOL-BASED POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-11-27 | — | — | WO | disclosed |
| EP-1363733-B1 | TUBULAR REACTOR WITH COAXIAL CYLINDERS AND PROCESS USING THIS REACTOR | CIBA SPEC CHEM WATER TREAT LTD (GB) | 2008-08-20 | — | — | EP | disclosed |
| US-20070122392-A1 | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301525-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | PLOD3, CUTA, PLOD2 | PARP10 1804/4885KMT2A 4079/4885ELANE 245/4885 |
| US-20110008277-A1 | POLYOL-BASED POLYMERS | SORD, SUCLG2, SUCLG1 | PARP10 877/4885KMT2A 2272/4885ELANE 4444/4885 |
| US-20110182957-A1 | CELLULOSICS FOR TISSUE REPLACEMENT | CUTA, PLOD2, LIPG | PARP10 2974/4885KMT2A 3952/4885ELANE 164/4885 |
| US-20110189253-A1 | BIOMATERIAL COMPOSITION AND METHOD | ILK, KIT, CAD | PARP10 1570/4885KMT2A 1997/4885ELANE 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.